Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis

Conclusions Our findings indicate that in women with MS treated with NTZ before conception, continuation of NTZ throughout pregnancy and its early resumption after delivery mitigate the risk of clinical and radiological reactivation. This approach has no major impact on newborns’ outcomes.

http://jnnp.bmj.com/cgi/content/short/93/12/1306?rss=1

Source: Journal of Neurology, Neurosurgery and Psychiatry - November 14, 2022 Category: Neurosurgery Authors: Landi, D., Bovis, F., Grimaldi, A., Annovazzi, P. O., Bertolotto, A., Bianchi, A., Borriello, G., Brescia Morra, V., Bucello, S., Buscarinu, M. C., Caleri, F., Capobianco, M., Capra, R., Cellerino, M., Centonze, D., Cerqua, R., Chisari, C. G., Clerico, M. Tags: Multiple sclerosis Source Type: research